Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults

Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Chompoonut Auphimai, Donchida Srimuan, Thaksaporn Thatsanatorn, Suvichada Assawakosri, Sitthichai Kanokudom, Yong Poovorawan
doi: https://doi.org/10.1101/2021.11.04.21265908

Data Availability

All data produced in the present work are contained in the manuscript.

Back to top
Posted November 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccines in healthy adults
Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Chompoonut Auphimai, Donchida Srimuan, Thaksaporn Thatsanatorn, Suvichada Assawakosri, Sitthichai Kanokudom, Yong Poovorawan
medRxiv 2021.11.04.21265908; doi: https://doi.org/10.1101/2021.11.04.21265908
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area